Barcelona Science Park
The Barcelona Science Park is a meeting point where university, business and society come together. Its objective is to promote innovation, particularly in the life sciences. Founded by the University of Barcelona in 1997, it was the first science park in Spain and is an international point of reference today in the promotion of innovation, with more than 2.000 professionals working there. The Barcelona Science Park has as its goals:
- To potentiate quality research with the support of a wide range of technologies
- To revitalise the relation between university and business
- To promote the creation of new companies and institutions
- To further the science-society dialogue and encourage careers in science
At present the park is home to research institutes, companies, an incubator for biotechnology companies and a wide range of research support technology. In addition, it organizes more than 120 activities for the promotion of scientific culture and new careers in science, in which close to 6.000 people participate each year.
Biocat is the organization that coordinates, dynamizes and promotes biotechnology, biomedicine and medical technology sector in Catalonia. It is fostered by the Government of Catalonia and the Barcelona City Council and, since it was created in 2006, has included companies and organizations from the sector (research centres, hospitals, universities…) in its governing bodies. Biocat works to achieve the following goals:
- Facilitate relationships and synergies among members of the BioRegion of Catalonia.
- Drive the sector to make it an economic engine in the country.
- Promote the sector on an international level.
- Improve the public’s knowledge and perception of biotechnology.
University Paul Sabatier, Toulouse III
Officially founded in 1969, University Toulouse III, Paul Sabatier (UPS) is one of the biggest universities in France. It offers a wide range of courses in science, technology, health, and human and social sciences. Each year, it welcomes 28.000 students and awards more than 11.000 degrees and diplomas. This campus is 31.987 students, 2.609 teachers and researchers and 1.980 staff. The pole “Life Sciences” is highly structured around excellence networks with complementary skills. It includes more than 1.200 permanent staff members in 20 mixed research and services units, 11 welcoming teams, 2 university laboratories and 5 federative structures, whose work covers the whole of the thematic fields of biology. The structuration of this cluster was impulsed by the creation, more than 10 years ago, of a GENOTOUL network with a view to setting up powerful high technology platforms for the whole scientific community. Toulouse has also been a leader in the field of training biology doctoral students, by the creation of one of the first Biology Health Biotechnology doctoral schools whose organization has been reproduced later on in other universities.
CAPTOR Project – Investissement d’Avenir
The CAPTOR project (Cancer Pharmacology of Toulouse Oncopole and Region) is one of the two French PHUC’s (Pôle Hospitalo-Universitaire du Cancer) and has been bearer of the program “Investing for the Future”. CAPTOR is the federative project for the Toulouse Oncopole and benefits from the skills and experiences of Toulouse III – Paul Sabatier University, CHU in Toulouse, Institut Claudius Regaud, Inserm, CNRS, and industrials partners like Laboratoires Pierre Fabre or Sanofi. CAPTOR has incorporated the three main dimensions of the universal fight against cancer (care, research and education) with four priority areas: innovation (WP1), drug evaluation (WP2), social pharmacology (WP3) and education (WP4).
Fondation Toulouse Cancer Santé
Fondation Toulouse Cancer Santé is a research foundation created by 5 worldwide private companies (Amgen – GSK – Pierre Fabre – Siemens – Total) involved in research and innovation, which has been state-approved May 5th 2006, with a special endowment of ANR, the French agency for research. The aim of the Foundation is to define, promote and finance cooperative actions to develop research and industry in the life sciences and especially in oncology by supporting the highly innovative areas that are: Nano & Bio & Information Technologies and also Radiotherapy and Imaging techniques (“NBI Tech 2 Life”). Based on the Oncopole, in Toulouse, which is a campus, unique in Europe, that brings together on a single site public and private research, academic organizations, industry including pharmaceutical leaders and SMEs, medical and clinical expertise. These actors are committed to working together to achieve a single goal: more effectively fight cancer. By co-organizing the Summer School on Medicines since the first edition, Fondation Toulouse Cancer Santé shows its involvement in multidisciplinary education dedicated to students in life sciences and health, but also in technological sciences.
Université de Montréal
Founded in 1878, the Université de Montréal, with its two affiliated schools, the École Polytechnique and the HEC Montréal, is now the largest university in Quebec and the second largest in Canada, with over 64.000 students, including nearly 8.000 from around the world, and more than 11.000 diplomas awarded at every university level each year. Deeply rooted in Montréal and dedicated to its international mission, the Université de Montréal is one of the top universities in the French-speaking world and is ranked 126th on the list of top international institutions by the prestigious QS World University Rankings. The Faculty of pharmacy at Université de Montréal is one of the largest faculties of pharmacy in Canada. In 2016, nearly 1.000 students were enrolled in undergraduate studies and more than 250 students were pursuing graduate studies.
Groupe de recherche universitaire sur le médicament (GRUM)
The University Drug Research Group (GRUM), resarchers at the Université de Montréal, was established in November 2004 in order to develop and support transdisciplinary research, researcher training and technology transfer relating to drug discovery, development and evaluation. It will be a hub for developing and increasing collaborative undertakings and exchanges between scientists exploring all aspects of drug discovery and development, including evaluation of how drugs affect population health.
Universidade de São Paulo
The University of São Paulo (USP) is a public University in the Brazilian state of São Paulo founded in 1934. It is the largest Brazilian public University and the country’s most prestigious educational institution, being recently ranked 51-60 worldwide in reputation by the Times Higher Education World University Rankings. USP is one of the largest institutions of higher education in Latin America, with approximately 95,000 enrolled students. Currently, it has eleven campuses, four of them in the city of São Paulo, two in São Carlos, and the remaining campuses in the cities of Bauru, Lorena, Piracicaba, Pirassununga, and Ribeirão Preto. USP is involved in teaching, research, and extension activities in all areas of knowledge. In terms of research, USP is Brazil’s largest research institution, producing more than 25% of the scientific papers published by Brazilian researchers in high quality conferences and journals